is an innovative high-tech enterprise focusing on the R&D, production and application of new cyclodextrin materials. Founded in 2010,covers area 30000m² , construction area 10000m², GMP workshop 2000m²,R&D, testing and laboratories 2000m², fixed assets 150 million yuan, testing instruments value more than 20 million yuan. We have advance R&D, quality inspection center and professional research team, maintains long-term cooperative relationship with Nankai University and Shandong University, and have many R&D platforms.
Carboxymethyl-β-cyclodextrin (CM-β-CD), as one of cyclodextrin derivatives, is mainly prepared by reacting cyclodextrin with chloroacetic acid in an alkaline environment. The reaction process is easy to operate and the yield is high. And CM-β-CD contains carboxyl anion, which has high solubility and
The weight components of a gynecological antibacterial gel prepared with the participation of hydroxypropyl gamma cyclodextrin are as follows: 0.51.5 part of tragacanth gum, 0.61 part of juniper oil, 0.30.7 part of Houttuynia cordata extract, mugwort extract 0.10.4 part of geranium extract, 0.20.6 p
Erlotinib is a targeted drug that can specifically target tumor cells and inhibit tumor formation and growth. However, its solubility is not ideal. In order to improve this situation, some researchers have included it with cyclodextrin derivatives to achieve the desired effect.Therefore, researchers
Fentanyl, a synthetic opioid agonist, is a potent analgesic used during anaesthesia and analgesia, generally by injection. Researchers have investigated the potential of betadex sulfobutyl ether sodium(SBECD) and hydroxypropyl beta cyclodextrin (HPBCD) as an adjunct to improve the efficacy of fentan